Aehr Test Systems (AEHR) — SEC Filings
Aehr Test Systems (AEHR) — 33 SEC filings. Latest: 424B5 (Apr 8, 2026). Includes 16 8-K, 6 10-Q, 3 SC 13G/A.
View Aehr Test Systems on SEC EDGAR
Overview
Aehr Test Systems (AEHR) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 8-K filed on Oct 21, 2025: AEHR TEST SYSTEMS filed an 8-K on October 21, 2025, reporting on matters submitted to a vote of security holders as of October 20, 2025. The filing details corporate actions and governance, with the company incorporated in California and headquartered in Fremont.
Sentiment Summary
Across 33 filings, the sentiment breakdown is: 5 bullish, 1 bearish, 24 neutral, 3 mixed. The dominant filing sentiment for Aehr Test Systems is neutral.
Filing Type Overview
Aehr Test Systems (AEHR) has filed 1 424B5, 16 8-K, 6 10-Q, 2 DEF 14A, 2 10-K, 3 SC 13G/A, 3 SC 13G with the SEC between Jan 2024 to Apr 2026.
Filings by Year
Recent SEC Filings (33)
Risk Profile
Risk Assessment: Of AEHR's 23 recent filings, 1 were flagged as high-risk, 7 as medium-risk, and 15 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.
Financial Highlights
| Metric | Value |
|---|---|
| Revenue | $10.969M |
| Net Income | $(2.084)M |
| EPS | $(0.07) |
| Cash Position | $22.708M |
| Total Assets | $144.092M |
| Total Debt | $21.698M |
Key Executives
- Gayn Erickson
- Rhea J. Posedel
- Fariba Danesh
- Laura Oliphant
- Geoffrey G. Scott
- Howard T. Slayen
- Chris P. Siu
- Gary J. Spach
Industry Context
AEHR Test Systems operates in the semiconductor testing equipment market. This industry is characterized by high R&D investment, cyclical demand tied to semiconductor manufacturing cycles, and intense competition from global players. Recent trends include increasing complexity of chips requiring more advanced testing solutions and a growing demand for outsourced semiconductor assembly and test (OSAT) services.
Top Tags
financial-reporting (5) · 8-k (4) · financials (4) · corporate-governance (3) · revenue-growth (3) · earnings (3) · shareholder-vote (2) · sec-filing (2) · financial-condition (2) · results-of-operations (2)
Key Numbers
| Metric | Value | Context |
|---|---|---|
| Revenue | $10.969M | Decreased by 16.4% from $13.119M in Q1 2024 |
| Net Loss | $(2.084)M | Swing from $0.660M net income in Q1 2024 |
| Diluted EPS | $(0.07) | Decreased from $0.02 in Q1 2024 |
| Gross Profit | $3.719M | Decreased by 47.4% from $7.078M in Q1 2024 |
| Cost of Revenue | $7.250M | Increased from $6.041M in Q1 2024 |
| Restructuring Charges | $219K | New expense in Q1 2025, not present in Q1 2024 |
| Cash and Cash Equivalents | $22.708M | Decreased from $24.529M at May 30, 2025 |
| Net Cash from Operating Activities | $(0.282)M | Reversal from $2.380M provided in Q1 2024 |
| Customer A Revenue Concentration | 42.6% | Percentage of total revenues for Q1 2025 |
| Purchases of Property and Equipment | $1.391M | Increased from $0.197M in Q1 2024 |
| Additional shares for 2023 Equity Incentive Plan | 2,500,000 | Proposed increase in shares reserved for issuance |
| Additional shares for 2006 Employee Stock Purchase Plan | 300,000 | Proposed increase in shares reserved for issuance |
| Shares of common stock outstanding | 29,968,988 | As of Record Date August 28, 2025, entitled to vote |
| Annual Meeting Date | October 20, 2025 | Date of the 2025 Annual Meeting of Shareholders |
| Record Date | August 28, 2025 | Shareholders of record entitled to vote |
Frequently Asked Questions
What are the latest SEC filings for Aehr Test Systems (AEHR)?
Aehr Test Systems has 33 recent SEC filings from Jan 2024 to Apr 2026, including 16 8-K, 6 10-Q, 3 SC 13G/A. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of AEHR filings?
Across 33 filings, the sentiment breakdown is: 5 bullish, 1 bearish, 24 neutral, 3 mixed. The dominant sentiment is neutral.
Where can I find Aehr Test Systems SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Aehr Test Systems (AEHR) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Aehr Test Systems?
Key financial highlights from Aehr Test Systems's most recent 10-Q include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.
What is the investment thesis for AEHR?
The investment thesis for AEHR includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.
Who are the key executives at Aehr Test Systems?
Key executives identified across Aehr Test Systems's filings include Gayn Erickson, Rhea J. Posedel, Fariba Danesh, Laura Oliphant, Geoffrey G. Scott and 3 others.
What are the main risk factors for Aehr Test Systems stock?
Of AEHR's 23 assessed filings, 1 were flagged high-risk, 7 medium-risk, and 15 low-risk.
What are recent predictions and forward guidance from Aehr Test Systems?
Forward guidance and predictions for Aehr Test Systems are extracted from SEC filings as they are enriched.